tiprankstipranks
Trending News
More News >

Recce Pharmaceuticals Announces Quotation of New Securities on ASX

Story Highlights
Recce Pharmaceuticals Announces Quotation of New Securities on ASX

Confident Investing Starts Here:

Recce Pharmaceuticals Ltd. ( (AU:RCE) ) has issued an update.

Recce Pharmaceuticals Ltd has announced the quotation of 12,273,033 ordinary fully paid securities on the Australian Securities Exchange (ASX) as of May 16, 2025. This move is part of previously announced transactions and is expected to enhance the company’s financial position, potentially impacting its market presence and stakeholder interests positively.

More about Recce Pharmaceuticals Ltd.

Recce Pharmaceuticals Ltd is a company operating in the pharmaceutical industry, focusing on the development and commercialization of novel synthetic anti-infectives designed to address the growing problem of antibiotic-resistant superbugs and emerging viral pathogens.

Average Trading Volume: 218,078

Technical Sentiment Signal: Sell

Current Market Cap: A$79.8M

Find detailed analytics on RCE stock on TipRanks’ Stock Analysis page.

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.

Report an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App